Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 278 | 949 | 6,158 | 928 | 3,420 |
| Cost of Goods | 37 | 1 | 46 | 185 | 51 |
| Gross Profit | 241 | 948 | 6,112 | 742 | 3,369 |
| Operating Expenses | 17,523 | 4,979 | 11,580 | 7,181 | 8,416 |
| Operating Income | -17,282 | -4,031 | -5,468 | -6,439 | -5,046 |
| Interest Expense | 30 | 100 | 56 | 1 | 0 |
| Other Income | 665 | -2,271 | -4,214 | 4,032 | -413 |
| Pre-tax Income | -16,647 | -6,402 | -9,738 | -2,407 | -5,459 |
| Income Tax | 0 | -3,856 | N/A | 0 | 101 |
| Net Income Continuous | -16,647 | -2,546 | -9,738 | -2,407 | -5,560 |
| Net Income Discontinuous | N/A | N/A | N/A | 0 | 1,900 |
| Net Income | $-16,647 | $-2,546 | $-9,737 | $-2,407 | $-3,660 |
| EPS Basic Total Ops | -0.57 | -0.40 | -0.05 | -0.01 | -0.03 |
| EPS Basic Continuous Ops | -0.57 | -0.40 | -0.05 | -0.01 | -0.04 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.00 | 0.01 |
| EPS Diluted Total Ops | -0.57 | -0.40 | -0.05 | -0.01 | -0.03 |
| EPS Diluted Continuous Ops | -0.57 | -0.40 | -0.05 | -0.01 | -0.04 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.00 | 0.01 |
| EBITDA(a) | $-15,096 | $-5,489 | $-8,831 | $-1,446 | $-4,312 |